Low On-Treatment Platelet Reactivity Predicts Long-Term Risk of Bleeding After Elective PCI

Mirko D Čolić1, Branko M Čalija1, Bratislav M Milosavljević1

  • 1Dedinje Cardiovascular Institute, Belgrade, Serbia.

Insights

Enhanced platelet responsiveness to adenosine diphosphate (ADP) predicts bleeding events after percutaneous coronary interventions (PCI). Lower ADP-induced platelet aggregation after PCI is linked to increased bleeding risk, highlighting its predictive value.

Area of Science:

  • Cardiology
  • Hematology
  • Interventional Cardiology

Background:

  • Bleeding is a significant complication following percutaneous coronary interventions (PCI).
  • This complication negatively impacts patient prognosis.
  • Understanding predictors of bleeding is crucial for patient management.

Purpose of the Study:

  • To assess the predictive capability of platelet responsiveness to dual antiplatelet therapy (aspirin and clopidogrel) for bleeding events.
  • To identify key factors associated with bleeding post-elective PCI.

Main Methods:

  • Multiple electrode aggregometry (MAE) was used to measure platelet function (ASPI and ADP).
  • Tests were conducted before and 24 hours after PCI in 481 patients.
  • Patients were followed for an average of 15.34 months, monitoring bleeding (BARC classification) and ischemic events.

Main Results:

  • The incidence of any bleeding, BARC ≤2, and BARC ≥3 bleeding was 19%, 18%, and 1%, respectively.
  • Lower MAE ADP test values 24 hours post-PCI were associated with increased bleeding (any and BARC ≤2).
  • Independent predictors for bleeding included female gender, prior myocardial infarction, lower body mass, and MAE ADP test results.

Conclusions:

  • The MAE ADP test, performed before and after PCI, is a valuable predictor of bleeding events.
  • Enhanced platelet responsiveness to ADP is associated with a higher risk of bleeding after elective PCI.
  • These findings can aid in risk stratification and personalized antiplatelet therapy management.
Abstract

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.7K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
554